Consolidation over , shares will begin move substantially higher in 2025 |
tick, tick....... |
Thank you socionomics.
Not that anybody needs to know but I bought and sold these at a profit when they announced during Covid.
'hazl - 09 Feb 2021 - 10:03:28 - 130482 of 194815 Share Ideas: macro & micro. - SHA
Have taken some GDR off the table.'
Since then I have always intended to keep a core holding. |
No. I want to see good companies thrive, and patients being saved from their needs being compromised, by a simple error, of giving them unsuitable treatment and medication. |
Hazl wants to ramp up the share and then dump it onto another individual |
hazl is a patient investor, who has averaged down. He is unshakable.
Blessed are the meek, for they shall inherit the earth. |
Hazl is £80K when it bought in big at £2 during COVID rise. |
10274
These products ought to SAVE the NHS money.
Think about the repeat hospital appointments for a child that presents as deaf for example. |
Would be nice to see the next leg here, with volume pushing it through 2.5s and a new consolidation point nearer 3s for starters, GLA |
Did you watch the news today? ST Helier hospital never got the funds they were promised. What makes you think the NHS would fund the GDR kit? |
And personalised medicine where GDR has Government support, also. |
You don't know the meaning of cheap, try again at 0.5p |
'
This validation study demonstrates the Genedrive CYP2C19 ID Kit to have a high diagnostic accuracy for clinically relevant CYP2C19 variation. The platform had a superior performance to the reference test, with a higher accuracy and lower failure rate. Implementation of the Genedrive CYP2C19 ID Kit in clinical practice could provide an accurate, rapid, cost-effective, and noninvasive alternative to standard laboratory testing and ensures results are available in a clinically relevant format and time frame to guide patient care.
' |
No one is vetting against this hazl. Go look at his other posts - all purple/Z1co based ones. |
What I attempt to do is to point out the qualities of the investment and any news, indirect as well as directm rather than make it about the posters. |
Again we had the opportunity to buy up ridiculously cheap shares here at one point.
I knew that traders like those who shall be nameless above, would trade them, as they
did, so I did similarly, keeping a core holding.
If you like a company that has little abilty to get revenue, early on, you have to duck and dive a bit, to protect your capital.
So the poster is quite wrong about the reference in post 10264. |
I think it's purely about some of us providing a good argument on the company's case,
when he is betting against it beeks. |
Hazl is £80K down on this share and is desperate to get his money back |
3 January 2025
Find out why discovery science is a vital UK asset.
Our latest £80 million investment in new discovery-led research projects underscores our commitment to fostering a vibrant UK national research capability. It is an investment in the brightest ideas and teams, and as the Head of Theme for Physical Sciences, I am inspired by the creativity and passion of our discovery research community.
For me, playing a part in convening and enabling our communities to fulfil their research vision is a rewarding aspect of my job, and these projects and their journey represents this.
Discovery research thrives on the unknown, the unexpected, and the unexplored. It’s not just important; it’s indispensable. Here’s why: |
UK stocks are getting bashed left and right this won't survive on the next market crash |
Interesting here though to see which companies responded in messages below Genedrive's piece. |
link won't work. |
Register for real-time alerts, custom portfolio, and market movers
Hot Features
Premium
